Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Stomach Neoplasms 2Breast Neoplasms 2Smoldering Multiple Myeloma 1Psychological Well-Being 1Ovarian Neoplasms 1Neoplasms, Second Primary 1Multiple Myeloma 1Motor Activity 1Monoclonal Gammopathy of Undetermined Significance 1Lung Neoplasms 1Limited Stage Small Cell Lung Cancer 1Helicobacter Infections 1Fatigue Syndrome, Chronic 1Esophageal Neoplasms 1Diarrhea 1Breast Carcinoma In Situ 1

Interventions

Dexamethasone 4iberdomide 2dexamethasone acetate 2dexamethasone 21-phosphate 2auricularum 2Lenalidomide 2Curcumin 2Calcium Dobesilate 2selinexor 1isatuximab 1daratumumab 1Resistance Training 1Propranolol 1Probiotics 1Docosahexaenoic Acids 1Dietary Fiber 1Diet, Plant-Based 1Diet, Mediterranean 1Blood Specimen Collection 1Behavior Therapy 1Adrenergic beta-Antagonists 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Smoldering Multiple Myeloma × Probiotics × Clear all
NCT06055894 2025-11-13

A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS)

Memorial Sloan Kettering Cancer Center

Phase NA Recruiting
200 enrolled
Plasma cell

Smoldering Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡